pyrvinium has been researched along with Invasiveness, Neoplasm in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fei, X; Hu, C; Liang, S; Xu, L; Yan, N; Zhang, F; Zhang, L; Zhang, Y | 1 |
1 other study(ies) available for pyrvinium and Invasiveness, Neoplasm
| Article | Year |
|---|---|
WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; CD24 Antigen; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Humans; Hyaluronan Receptors; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplastic Stem Cells; Polymerase Chain Reaction; Pyrvinium Compounds; Wnt Signaling Pathway | 2016 |